Difficulty: Medium
Average Score: 74%
Practice
A 70-year-old woman with a history of osteoporosis is prescribed raloxifene. Raloxifene works by:
Correct answer
A
Rationale
In the context of pharmacological lifespan treatment, understanding how medications work is crucial for effective patient care. In this scenario, the correct answer is A) Inhibiting osteoclast-mediated bone resorption. Raloxifene is a selective estrogen receptor modulator (SERM) that acts by binding to estrogen receptors in bone tissue, thereby inhibiting osteoclast activity, which are cells responsible for bone resorption. By inhibiting osteoclasts, raloxifene helps maintain bone density and reduce the risk of fractures in conditions like osteoporosis.
Option B) Promoting osteoblast activity is incorrect because raloxifene primarily targets osteoclasts, not osteoblasts which are responsible for bone formation. Option C) Increasing calcium absorption in the intestines is not the primary mechanism of action of raloxifene. Option D) Inhibiting collagen synthesis is also incorrect as raloxifene's main action is on bone resorption, not collagen synthesis.
Educationally, this question highlights the importance of understanding the specific mechanisms of action of pharmacological agents in treating conditions like osteoporosis. It emphasizes the need for healthcare providers to have a solid foundation in pharmacology to make informed decisions when prescribing medications to optimize patient outcomes.
Option B) Promoting osteoblast activity is incorrect because raloxifene primarily targets osteoclasts, not osteoblasts which are responsible for bone formation. Option C) Increasing calcium absorption in the intestines is not the primary mechanism of action of raloxifene. Option D) Inhibiting collagen synthesis is also incorrect as raloxifene's main action is on bone resorption, not collagen synthesis.
Educationally, this question highlights the importance of understanding the specific mechanisms of action of pharmacological agents in treating conditions like osteoporosis. It emphasizes the need for healthcare providers to have a solid foundation in pharmacology to make informed decisions when prescribing medications to optimize patient outcomes.